A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology


Por: Pentz, R, Iulita, MF, Mikutra-Cencora, M, Ducatenzeiler, A, Bennett, DA, Cuello, AC

Publicada: 1 ene 2021
Resumen:
Matrix metalloproteinase-3 (MMP-3) has been associated with risk of Alzheimer's disease (AD). In this study we introduce a novel role for MMP-3 in degrading nerve growth factor (NGF) in vivo and examine its mRNA and protein expression across the continuum of AD pathology. We provide evidence that MMP-3 participates in the degradation of mature NGF in vitro and in vivo and that it is secreted from the rat cerebral cortex in an activity dependent manner. We show that cortical MMP-3 is upregulated in the McGill-R-Thy1-APP transgenic rat model of AD-like amyloidosis. A similar upregulation was found in AD and MCI brains as well as in cognitively normal individuals with elevated amyloid deposition. We also observed that frontal cortex MMP-3 protein levels are higher in males. MMP-3 protein correlated with more AD neuropathology, markers of NGF metabolism, and lower cognitive scores in males but not in females. These results suggest that MMP-3 upregulation in AD might contribute to NGF dysmetabolism, and therefore to cholinergic atrophy and cognitive deficits, in a sex-specific manner. MMP-3 should be further investigated as a biomarker candidate or as a therapeutic target in AD.

Filiaciones:
Pentz, R:
 McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada

Iulita, MF:
 McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada

 Univ Autonoma Barcelona, Biomed Res Inst St Pau, St Pau Memory Unit, Dept Neurol,Hosp Santa Creu & St Pau,Biomed Res I, Barcelona, Spain

Mikutra-Cencora, M:
 McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada

Ducatenzeiler, A:
 McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada

Bennett, DA:
 Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA

Cuello, AC:
 McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada

 McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada

 McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada

 Univ Oxford, Dept Pharmacol, Oxford, OH USA
ISSN: 09699961





NEUROBIOLOGY OF DISEASE
Editorial
ACADEMIC PRESS INC ELSEVIER SCIENCE, 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA, Reino Unido
Tipo de documento: Article
Volumen: 148 Número:
Páginas:
WOS Id: 000607576400009
ID de PubMed: 33130223
imagen gold, Green Accepted

MÉTRICAS